Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-001823

Options or other derivatives

  • 10% owner bought 8,695,653 shares

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mayne Pharma Ventures Pty Ltd 10% owner 2018-01-10 Purchase · Series B Convertible Preferred Stock +3,478,261 3,478,261 D: show line 1 in the form
Mayne Pharma Ventures Pty Ltd 10% owner 2018-01-10 Purchase · Series A Warrants to Purchase Common Stock +2,608,696 2,608,696 D: show line 2 in the form
Mayne Pharma Ventures Pty Ltd 10% owner 2018-01-10 Purchase · Series B Warrants to Purchase Common Stock +2,608,696 2,608,696 D: show line 3 in the form
Loading xslF345X03/tv483130_4.xml…